Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer

Junnan Xu(China Medical University), Mingxi Jing(China Medical University)
Oncology Letters
December 19, 2017
Cited by 13


Related Papers